Entrepreneur, television star, owner of the NBA's Dallas Mavericks, and now PBM disruptor Mark Cuban drops in this week to talk about his newest passion, Cost Plus Drugs, which is turning the industry upside down. Cuban is joined by Cost Plus Drug VP of Pharmacy Relations and Chief Privacy Officer Erin Albert, and well-known industry analyst Antonio Ciaccia. They bat it around with NCPA CEO Douglas Hoey for this very special episode of Independent Rx Forum. https://tccforms.webflow.io/form-one

In this episode, Jack Mozloom checks in with Elise Damman and Becky Snead of the NCPA Innovation Center to preview the education programming at the upcoming NCPA Annual Convention, happening Oct. 26-29 in Columbus, Ohio. Learn more at ncpa.org/annual-convention.

Marty Makary, MD, MPH, is a surgeon and researcher at Johns Hopkins University. He is a best-selling author (Unaccountable and The Price We Pay), and editorial writer for the Washington Post, the Wall Street Journal, and other major publications. Makary was a keynote speaker at last year’s NCPA Annual Convention, and he’s sitting down with NCPA CEO Douglas Hoey to discuss his new book, Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health.